Sorrento Therapeutics, Inc. Financial Ratios — SRNE Stock

Profitability (USD)

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Return on Common Equity (%)	- -	- -	-43.66	-69.65	-93.11	-60.02	-39.49	-36.09	-54.11	6.53	-99.52	-202.78	-244.9	-351.23	- -
Return on Assets (%)	-235.34	-53.03	-39.14	-63.11	-85.37	-44.1	-29.61	-18.89	-16.35	2.19	-38.56	-49.43	-54.59	-69.61	-98.12
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	100	100	100	99.13	46.59	57.52	90.05	97.4	66.69	61.07	75.14	75.37	46.77
EBITDA Margin (%)	- -	- -	-262.06	-582.64	-780.65	-3,128.7	-819.58	-1,037.52	-699.37	38.57	-566.14	-586	-476.46	-672.13	-581.26
Operating Margin (%)	- -	- -	-265.49	-612.72	-830.82	-3,409.13	-902.82	-1,089.15	-734.76	33.87	-610.94	-620.97	-503.99	-695.68	-602.33
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	77.48	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	-611.6	-829.62	-4,763.26	-950.56	-211.74	-800.64	10.09	-1,008.73	-1,143.98	-776.72	-874.28	-893.95
Profit Margin (%)	- -	- -	-264.94	-611.6	-829.62	-4,763.26	-906.07	-998.06	-747.34	6.01	-960.41	-929.21	-746.41	-809.63	-911.6
Net Income to Common Margin (%)	- -	- -	-264.94	-611.6	-829.62	-4,763.26	-906.07	-998.06	-747.34	6.01	-960.41	-929.21	-746.41	-809.63	-911.6
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	-43.66	-69.65	-93.11	-60.02	-39.49	-36.09	-54.11	6.53	-99.52	-202.78	-244.9	-351.23	- -

Credit (USD)

Credit Ratios API ChatGPT

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Total Debt	- -	- -	- -	- -	- -	5	12	9	47	5	233	291	169	238	135
ST Debt	- -	- -	- -	- -	- -	- -	3	5	- -	- -	10	40	27	44	30
LT Debt	- -	- -	- -	- -	- -	4	9	4	47	5	223	251	143	194	104
Total Debt/EBITDA	- -	- -	- -	- -	- -	-0.33	-0.39	-0.19	-0.83	0.09	-1.94	-1.58	-0.89	-0.67	-0.37
Net Debt/EBITDA	- -	3.61	2.95	1.12	1.12	1.87	1.91	0.63	0.62	-0.26	-0.62	-1.16	-0.31	-0.3	-0.03
Total Debt/EBIT	- -	- -	- -	- -	- -	-0.31	-0.35	-0.18	-0.79	0.1	-1.8	-1.49	-0.84	-0.65	-0.36
Net Debt/EBIT	- -	3.59	2.91	1.07	1.05	1.71	1.73	0.6	0.59	-0.3	-0.58	-1.09	-0.29	-0.29	-0.03
EBITDA to Interest Expense	- -	- -	- -	- -	- -	-56.89	-19.24	-28.83	-35.41	11.76	-2.08	-5.26	-9.45	-34.78	-42.6
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	-60.57	-19.61	-31.07	-39.67	9.56	-2.28	-5.58	-11.32	-35.65	-44.19
EBIT to Interest Expense	- -	- -	- -	- -	- -	-61.98	-21.2	-30.26	-37.2	10.33	-2.25	-5.57	-10	-36	-44.15
Interest Expense	- -	- -	- -	- -	- -	- -	2	2	2	5	58	35	20	10	9
Common Equity/Total Assets	- -	90.07	89.38	92.13	91.39	72.16	76.81	42.25	19.93	46.24	33.56	14.09	30.82	11.33	-3.93
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	6.63	8.12	3.12	54.46	2.52	107.54	766.88	101.3	248.38	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	6.19	7.31	2.93	35.2	2.46	50.62	77.64	45.97	61.47	92.47
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	4.79	6.24	1.28	11.73	1.21	35.75	45.05	26.61	27.93	22.07
Total Debt/Equity (%)	- -	- -	- -	- -	- -	7.19	11.17	6.55	54.7	2.52	112.43	887.72	120.37	304.08	-620.72
Total Debt/Capital (%)	- -	- -	- -	- -	- -	6.71	10.05	6.15	35.36	2.46	52.93	89.88	54.62	75.25	119.2
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	5.19	8.58	2.69	11.78	1.21	37.38	52.15	31.61	34.19	28.45
Net Debt to Equity	- -	-107.16	-103.81	-82.35	-82.15	-40.21	-54.97	-21.15	-40.56	-7.37	35.93	649.74	41.93	135.6	-54.37
Net Debt/Capital (%)	- -	1,496.63	2,723.85	-466.6	-460.29	-67.24	-122.06	-26.82	-68.23	-7.95	26.43	70.7	23.26	37.97	13.21
EBITDA	- -	-1	-2	-3	-5	-14	-31	-48	-57	59	-120	-184	-191	-356	-365
EBITDA-CapEx	- -	-1	-2	-4	-5	-15	-32	-51	-64	48	-131	-196	-228	-364	-379
Operating Income (Loss)	- -	-1	-2	-3	-5	-16	-35	-50	-60	51	-129	-195	-202	-368	-379

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Cash Ratio	- -	9.71	8.74	9.65	8.72	5.78	7.52	4.42	1.1	0.26	2.58	0.2	0.59	0.91	0.15
Current Ratio	- -	9.79	9.2	9.9	8.99	5.95	7.73	4.57	1.18	0.38	2.91	0.59	0.89	1.24	0.29
Quick Ratio	- -	9.71	9.15	9.82	8.85	5.85	7.6	4.5	1.14	0.31	2.65	0.32	0.75	1.04	0.23
CFO/Avg Current Liab	- -	-3.12	-3.23	-5.7	-8.05	-5.44	-3.83	-2.08	-1.33	-1.28	-1.59	-1.96	-1.51	-2.39	-1.26
Common Equity/Total Assets	- -	90.07	89.38	92.13	91.39	72.16	76.81	42.25	19.93	46.24	33.56	14.09	30.82	11.33	-3.93
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	6.63	8.12	3.12	54.46	2.52	107.54	766.88	101.3	248.38	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	6.19	7.31	2.93	35.2	2.46	50.62	77.64	45.97	61.47	92.47
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	4.79	6.24	1.28	11.73	1.21	35.75	45.05	26.61	27.93	22.07
Total Debt/Equity (%)	- -	- -	- -	- -	- -	7.19	11.17	6.55	54.7	2.52	112.43	887.72	120.37	304.08	-620.72
Total Debt/Capital (%)	- -	- -	- -	- -	- -	6.71	10.05	6.15	35.36	2.46	52.93	89.88	54.62	75.25	119.2
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	5.19	8.58	2.69	11.78	1.21	37.38	52.15	31.61	34.19	28.45
CFO/Total Liabilities	- -	-208.16	-256.11	-763.45	-649.98	-63.98	-87.62	-20.77	-22.51	-44.08	-26.83	-32.96	-40.38	-45.7	-59.42
CFO/CapEx	- -	-16.14	-33.6	-2.61	-6.93	-17.71	-48.67	-11.35	-10.34	-9.04	-9.98	-15.12	-4.25	-31.77	-21.52
Altman's Z-Score	- -	-0.26	-0.59	-3.26	-3.71	-1.79	-1.06	-0.58	-1.41	0.11	-1.5	-3.49	-4.7	-8.6	-16.45

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Accounts Receivable Turnover	- -	- -	- -	17.28	8.28	1.94	6.79	5.61	6.27	77.74	7.01	3.44	2.67	3.09	2.91
Days Sales Outstanding	- -	- -	- -	21.12	44.06	187.96	53.72	65.01	58.18	4.7	52.05	106.18	136.74	118.05	125.42
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	4.87	3.91	3.83	2.62	3.7
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	74.91	93.36	95.34	139.17	98.65
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	1.07	1.3	0.17	0.43	0.84	0.61	0.32	0.74	0.94
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	118,284.32	340.26	280.3	2,165.02	841.63	434.86	595.55	1,135.84	492.69	387.14
Cash Conversion Cycle	- -	- -	- -	- -	- -	-118,096.36	-286.53	-215.29	-2,106.84	-836.93	-307.9	-396.01	-903.76	-235.47	-163.07
Inventory to Cash Days	- -	- -	- -	- -	- -	187.96	53.72	65.01	58.18	4.7	-22.87	12.82	41.4	-21.12	26.77
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3	3	2	8	10
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3	7
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	5	3
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3	3	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Market Capitalization	- -	- -	- -	- -	- -	2	4	3	2	3	3	6	19	15	5
- Cash & Cash Equivalents	- -	3	5	3	5	32	72	39	82	20	159	23	56	37	24
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	-4	6	7	-2	-46	-24	-1	-3
+ Total Debt	- -	- -	- -	- -	- -	5	12	9	47	5	233	291	169	238	135
Enterprise Value	- -	-3	-5	-3	-5	-25	-56	-128	-27	-5	75	228	107	125	86
Total Capital	- -	3	5	4	6	72	121	150	134	212	441	324	310	316	113
Total Debt/Capital (%)	- -	- -	- -	- -	- -	6.71	10.05	6.15	35.36	2.46	52.93	89.88	54.62	75.25	119.2
Total Debt / EV	- -	- -	- -	- -	- -	-0.19	-0.22	-0.07	-1.74	-0.95	3.1	1.27	1.58	1.91	1.56
EV/Sales	- -	- -	- -	- -	- -	206.54	54.61	41.41	26.62	1.69	3.55	7.26	2.68	2.36	1.37
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	4.38	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	4.98	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	- -	- -	1	3	3	2	3	3	5	16	14	4
Diluted Enterprise Value	- -	-3	-5	-3	-5	-26	-57	-31	-26	-6	75	227	104	214	112
EV per Share	- -	- -	- -	- -	- -	6.31	7.83	5.15	4.31	3.68	0.62	1.36	0.39	0.4	0.17
TTM Sales	- -	- -	1	1	1	- -	4	5	8	152	21	31	40	53	63
TTM EBITDA	- -	-1	-2	-3	-5	-14	-31	-48	-57	59	-120	-184	-191	-356	-365
TTM Operating Income	- -	-1	-2	-3	-5	-16	-35	-50	-60	51	-129	-195	-202	-368	-379
TTM Cash Flow to Firm	- -	- -	- -	-3	-4	-16	-27	-34	-69	-82	-56	-138	-140	-272	-285
TTM Free Cash Flow to Firm	- -	- -	- -	-2	-3	-15	-27	-31	-62	-72	-45	-127	-102	-263	-272

Multiples (USD)

Valuation Multiples API ChatGPT

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Price/Free Cash Flow	- -	- -	- -	- -	- -	-0.08	-0.1	-0.08	-0.04	-0.03	-0.03	-0.03	-0.13	-0.05	-0.01
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	4.98	- -	- -	- -	- -	- -
Enterprise Value	- -	-3	-5	-3	-5	-25	-56	-128	-27	-5	75	228	107	125	86
Low Price	- -	- -	- -	- -	- -	0.08	0.03	0.07	0.04	0.02	0.02	0.01	0.02	0.05	0.01
EV/Sales	- -	- -	- -	- -	- -	206.54	54.61	41.41	26.62	1.69	3.55	7.26	2.68	2.36	1.37
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	4.38	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.29	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	- -	- -	-0.06	-0.06	-0.1	-0.05	0.22	-0.03	-0.01	-0.05	-0.06	-0.02
Price/Earnings High	- -	- -	- -	- -	- -	-0.07	-0.13	-0.22	-0.07	0.46	-0.06	-0.03	-0.15	-0.12	-0.04
Price/Earnings Low	- -	- -	- -	- -	- -	-0.05	-0.02	-0.06	-0.04	0.11	-0.01	-0.01	-0.01	-0.03	-0.01
Price/Book Value	- -	- -	- -	- -	- -	0.03	0.03	0.02	0.03	0.02	0.01	0.07	0.11	0.19	-0.25
Price/Book Value Average	- -	- -	- -	- -	- -	0.03	0.02	0.03	0.04	0.01	0.03	0.06	0.1	0.33	-0.58
Price/Book Value High	- -	- -	- -	- -	- -	0.04	0.05	0.07	0.05	0.03	0.06	0.14	0.32	0.69	-1.38
Price/Book Value Low	- -	- -	- -	- -	- -	0.03	0.01	0.02	0.03	0.01	0.01	0.03	0.03	0.19	-0.2
Price/Tangible Book Value	- -	- -	- -	- -	- -	0.2	0.05	0.03	-0.09	0.03	0.03	-0.25	0.39	-0.06	-0.02
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	0.21	0.03	0.04	-0.12	0.03	0.07	-0.2	0.35	-0.1	-0.05
Price/Tangible Book Value High	- -	- -	- -	- -	- -	0.25	0.07	0.08	-0.16	0.06	0.12	-0.47	1.11	-0.21	-0.11
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	0.19	0.01	0.02	-0.08	0.01	0.02	-0.1	0.09	-0.06	-0.02
Price/Sales	- -	- -	- -	- -	- -	2.65	0.7	0.7	0.3	0.02	0.12	0.14	0.39	0.26	0.06
Price/Sales Average	- -	- -	- -	- -	- -	2.88	0.5	0.98	0.39	0.01	0.28	0.12	0.35	0.46	0.14
Price/Sales High	- -	- -	- -	- -	- -	3.37	1.14	2.16	0.53	0.03	0.54	0.27	1.12	0.96	0.33
Price/Sales Low	- -	- -	- -	- -	- -	2.57	0.22	0.58	0.26	0.01	0.1	0.06	0.09	0.26	0.05
Price/Cash Flow	- -	- -	- -	- -	- -	-0.07	-0.09	-0.08	-0.03	-0.03	-0.02	-0.03	-0.1	-0.05	-0.01
Price/Cash Flow Average	- -	- -	- -	- -	- -	-0.08	-0.07	-0.11	-0.04	-0.02	-0.05	-0.02	-0.09	-0.09	-0.03
Price/Cash Flow High	- -	- -	- -	- -	- -	-0.09	-0.15	-0.24	-0.06	-0.04	-0.1	-0.05	-0.28	-0.18	-0.07
Price/Cash Flow Low	- -	- -	- -	- -	- -	-0.07	-0.03	-0.06	-0.03	-0.01	-0.02	-0.01	-0.02	-0.05	-0.01
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	-0.09	-0.07	-0.12	-0.05	-0.02	-0.06	-0.02	-0.11	-0.09	-0.03
Price/Free Cash Flow High	- -	- -	- -	- -	- -	-0.1	-0.16	-0.26	-0.07	-0.05	-0.11	-0.06	-0.37	-0.19	-0.07
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	-0.08	-0.03	-0.07	-0.03	-0.01	-0.02	-0.01	-0.03	-0.05	-0.01
EV/Sales Average	- -	- -	- -	- -	- -	229.42	34.7	90.69	35.05	1.25	3.75	7.22	2.63	4.28	1.89
EV/Sales High	- -	- -	- -	- -	- -	278.5	98.77	208.09	49.12	2.74	4.04	7.42	3.55	4.81	2.12
EV/Sales Low	- -	- -	- -	- -	- -	198.69	6	50.32	22.74	0.64	3.54	7.15	2.32	4.06	1.78
EV/EBITDA Average	- -	3.61	2.95	1.12	1.12	1.73	1.82	0.62	0.45	-0.1	-0.66	-1.23	-0.55	-0.64	-0.32
EV/EBITDA High	- -	3.61	2.95	1.12	1.12	1.7	1.72	0.5	0.43	-0.05	-0.71	-1.27	-0.74	-0.72	-0.37
EV/EBITDA Low	- -	3.61	2.95	1.12	1.12	1.74	1.87	0.66	0.46	-0.12	-0.62	-1.22	-0.49	-0.6	-0.31
EV/EBIT Average	- -	3.59	2.91	1.07	1.05	1.58	1.65	0.59	0.42	-0.11	-0.61	-1.16	-0.52	-0.61	-0.31
EV/EBIT High	- -	3.59	2.91	1.07	1.05	1.56	1.56	0.48	0.41	-0.06	-0.66	-1.2	-0.7	-0.69	-0.35
EV/EBIT Low	- -	3.59	2.91	1.07	1.05	1.6	1.7	0.63	0.44	-0.13	-0.58	-1.15	-0.46	-0.58	-0.29
Last Price	- -	- -	- -	- -	- -	0.08	0.1	0.09	0.05	0.04	0.02	0.03	0.07	0.05	0.01
High Price	- -	- -	- -	- -	- -	0.1	0.16	0.27	0.09	0.06	0.11	0.06	0.19	0.17	0.05
Enterprise Value Average	- -	-3	-5	-3	-5	-25	-57	-29	-25	-6	80	227	105	226	119
Enterprise Value High	- -	-3	-5	-3	-5	-24	-54	-24	-24	-3	86	233	142	255	134
Enterprise Value Low	- -	-3	-5	-3	-5	-25	-59	-31	-26	-7	75	225	93	215	112

Shares Outstanding	- -	9	10	10	12	23	36	38	51	83	122	168	275	315	515
Diluted Weighted Avg Shares	4	6	9	10	11	15	27	37	50	70	106	141	230	295	419
Basic Weighted Avg Shares	4	6	9	10	11	15	27	37	50	70	106	133	230	295	419
Revenue per Share	- -	- -	0.08	0.05	0.05	0.03	0.14	0.12	0.16	2.18	0.2	0.24	0.17	0.18	0.15
EBITDA per Share	-0.01	-0.16	-0.2	-0.31	-0.4	-0.96	-1.18	-1.29	-1.13	0.84	-1.13	-1.39	-0.83	-1.21	-0.87
Operating Income per Share	-0.01	-0.16	-0.21	-0.33	-0.43	-1.04	-1.29	-1.35	-1.19	0.74	-1.22	-1.47	-0.88	-1.25	-0.9
Basic EPS, GAAP	-0.01	-0.15	-0.2	-0.33	-0.42	-1.46	-1.3	-1.24	-1.21	0.13	-1.92	-2.2	-1.3	-1.45	-1.37
Basic EPS from Cont Ops	-0.01	-0.15	-0.2	-0.33	-0.42	-1.46	-1.3	-1.36	-1.27	0.16	-2	-2.73	-1.37	-1.46	-1.38
Diluted EPS, GAAP	-0.01	-0.15	-0.2	-0.33	-0.42	-1.46	-1.3	-1.24	-1.21	0.13	-1.92	-2.08	-1.3	-1.45	-1.37
Diluted EPS from Cont Ops	-0.01	-0.15	-0.2	-0.33	-0.42	-1.46	-1.3	-1.36	-1.27	0.16	-2	-2.58	-1.37	-1.46	-1.38
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	- -	-0.12	-0.18	-0.28	-0.33	-1.1	-1.08	-1.14	-1.41	-1.42	-1.05	-1.3	-0.69	-0.96	-0.7
Free Cash Flow per Basic Share	- -	-0.13	-0.18	-0.38	-0.38	-1.16	-1.1	-1.24	-1.54	-1.58	-1.16	-1.39	-0.86	-0.99	-0.73
Cash & Equivalents per Share	- -	0.38	0.53	0.33	0.42	1.38	1.99	3.61	1.64	0.25	1.3	0.13	0.21	0.4	0.1
Book Value per Share	-0.27	0.36	0.51	0.4	0.52	2.9	3	3.84	1.57	2.41	1.71	0.47	0.6	0.25	-0.04
Tangible Book Value per Share	-0.27	0.36	0.51	0.4	0.52	0.41	2.22	3.19	-0.52	1.09	0.86	-0.14	0.17	-0.83	-0.46

Sorrento Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)